EP Patent

EP3698794A1 — Compositions and methods for treating colitis

Assigned to Aerpio Therapeutics LLC · Expires 2020-08-26 · 6y expired

What this patent protects

Disclosed herein are compositions and methods for treating colitis and other inflammatory bowel diseases, inter alia, indeterminate colitis, Crohn's disease, irritable bowel syndrome and ischemic colitis.

USPTO Abstract

Disclosed herein are compositions and methods for treating colitis and other inflammatory bowel diseases, inter alia, indeterminate colitis, Crohn's disease, irritable bowel syndrome and ischemic colitis.

Drugs covered by this patent

Patent Metadata

Patent number
EP3698794A1
Jurisdiction
EP
Classification
—
Expires
2020-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Aerpio Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.